Author

L. R. Pease

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:mouse· 2 Assay:proteomics· 2 Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Research Focus:development & morphogenesis· 1 Research Focus:host-pathogen & immune response· 1

Frequent Co-Authors

M. J. Hansen· 2 shared A. J. Johnson· 1 shared A. Pandey· 1 shared B. T. Himes· 1 shared C. E. Fain· 1 shared C. K. Pfaller· 1 shared E. N. Goddery· 1 shared F. Jin· 1 shared

Activity by Year

2020-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 31 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

M. J. Hansen

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

PP2A catalytic subunit alpha is critically required for CD8+ T cell homeostasis and anti-bacterial responses

H. Zeng, X. Zhou, M. Li, M. Ai, Y. Li, X. Zhu, M. J. Hansen, J. Zhong, K. L. Johnson, R. Zenka, A. Pandey, L. R. Pease

This study shows that PP2A catalytic subunit alpha is essential for CD8+ T cell homeostasis and anti-bacterial responses, with Bcl2 rescue limited to spleen.

bioRxiv · Feb 6, 2024 · PreprintImmunology

Severe and multifaceted systemic immunosuppression caused by experimental cancers of the central nervous system requires release of non-steroid soluble mediators

K. Ayasoufi, C. K. Pfaller, L. Evgin, R. H. Khadka, Z. P. Tritz, E. N. Goddery, C. E. Fain, L. T. Yokanovich, B. T. Himes, F. Jin, J. Zheng, M. R. Schuelke, M. J. Hansen, W. Tung, L. R. Pease, , A. J. Johnson

This study identifies non-steroid soluble factors released by CNS cancers and injuries that cause systemic immunosuppression by inducing thymic and splenic involution and reducing MHC class II expression.

bioRxiv · Mar 24, 2020 · PreprintImmunology